Your session is about to expire
← Back to Search
Behavioral Intervention
Cognitive Rehabilitation for Traumatic Brain Injury (CRbTBI Trial)
N/A
Waitlist Available
Led By Yelena Bogdanova, PhD PhD
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Loss of consciousness (LOC) of 30 min or less
Age: 21-50
Must not have
Evidence of penetrating head injury
Hearing or vision impairment
Timeline
Screening 3 weeks
Treatment Varies
Follow Up ten weeks
Awards & highlights
No Placebo-Only Group
Summary
This trial looks at whether a structured rehabilitation program can help improve cognitive function and quality of life for people with bTBI.
Who is the study for?
This trial is for active-duty personnel or Veterans aged 21-50 who served in OEF/OIF and have mild traumatic brain injury from a blast with loss of consciousness under 30 minutes. It's not for those with penetrating head injuries, previous neurological diagnoses, psychotic disorders before the blast, or significant hearing/vision problems.
What is being tested?
The study tests how well a structured cognitive rehabilitation program can improve thinking skills and life quality in people with brain injuries caused by blasts. Participants will receive either cognitive interventions or educational sessions to aid their recovery.
What are the potential side effects?
Since this trial involves non-medical interventions like education and cognitive exercises, there are no typical drug side effects; however, participants may experience fatigue or frustration during challenging tasks.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have lost consciousness for 30 minutes or less.
Select...
I am between 21 and 50 years old.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have had a penetrating injury to my head.
Select...
I have a hearing or vision problem.
Select...
I have a history of neurological conditions.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ ten weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~ten weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Cognitive functioning
Secondary study objectives
Daily functioning
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Arm 1Experimental Treatment1 Intervention
Cognitive intervention
Group II: Arm 2Active Control1 Intervention
Educational intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Cognitive Intervention
2017
N/A
~1120
Find a Location
Who is running the clinical trial?
VA Office of Research and DevelopmentLead Sponsor
1,664 Previous Clinical Trials
3,765,520 Total Patients Enrolled
Yelena Bogdanova, PhD PhDPrincipal InvestigatorVA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA
1 Previous Clinical Trials
8 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have had a penetrating injury to my head.I have lost consciousness for 30 minutes or less.I have a hearing or vision problem.Military personnel or veterans who were exposed to explosions during Operation Enduring Freedom (OEF) or Operation Iraqi Freedom (OIF).I am between 21 and 50 years old.I have a history of neurological conditions.You had a mental illness like schizophrenia before the blast.You have a mild traumatic brain injury.
Research Study Groups:
This trial has the following groups:- Group 1: Arm 1
- Group 2: Arm 2
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger